Cardinal Health announces CVS extension while Cardinal Health stock trades above EUR 207.30

Published on 10/07/2026 at 15:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted earnings per share guidance is USD 12.40-12.60. Cardinal Health stock costs EUR 209.00 on October 7, 2026 after EUR 207.30, plus 0.82 percent.

Schwarzweiß-Reportage an der Verladerampe eines Pharma-Distributionszentrums — Cardinal Health Inc. zeigt eine SW-Reportage der Verladerampe im Pharma-Lager ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) was trading at EUR 209.00 at Lang & Schwarz on October 7, 2026 at 3:34 p.m. CEST, with a plus 0.82 percent change versus the prior close of EUR 207.30. On October 1, 2026, the company announced a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032, as reported in a SEC filing.

CVS visibility reaches 2032

The agreement keeps Cardinal Health's existing distribution scope with CVS Health in place through June 30, 2032. The filing also says the company reaffirmed fiscal 2027 non-GAAP earnings per share guidance of USD 12.40-12.60, equivalent to projected growth of 13 percent to 15 percent based on adjusted fiscal 2026 results.

That combination gives the latest company update two measurable anchors: a multiyear customer agreement and an unchanged earnings range. The long-term non-GAAP earnings per share growth target remains 12 percent to 14 percent, according to the same SEC filing.

Guidance sets the next test

Cardinal Health is scheduled to release first-quarter fiscal 2027 results before the New York Stock Exchange opens on November 5, 2026, with a webcast at 8:30 a.m. Eastern, according to the company's newsroom. The November report will give investors a new test of prescription volumes, specialty growth and profitability against the current earnings range.

In the fiscal fourth quarter of 2026, revenue increased 6 percent to USD 63.7 billion and GAAP diluted earnings per share increased 70 percent to USD 1.70, according to Cardinal Health's 2026 company news release listing. The reported comparison gives the upcoming fiscal 2027 guidance a recent operating benchmark.

USD range frames the valuation

The primary listing is on the New York Stock Exchange under ticker CAH. The stock's USD 151.87 to USD 258.30 52-week range, measured on October 7, 2026, places the current US-market reference at USD 234.65, while market capitalization stood at USD 55.0 billion.

Euro quote and prior close

Cardinal Health stock was trading at EUR 209.00 at Lang & Schwarz on October 7, 2026 at 3:34 p.m. CEST, with a plus 0.82 percent change versus the Lang & Schwarz prior close of EUR 207.30 on October 6, 2026. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.